Drug Topics Newsletter

To view this email as a web page, click here.

PHARMACISTS' REPORT

Five Tips for Evaluating Clinical Studies

Be an expert at evaluating clinical studies with some simple tools.

Self-Injectable Respiratory Medication Opens Doors for Patients with Severe Asthma

The first respiratory biologic to be approved for administration via an autoinjector will be available in the US soon.

Atrial Fibrillation Patients Often Overestimate Stroke and Bleeding Risks

Overestimating the bleeding risk of anticoagulants may lead to poor compliance.

Cybersecurity: Safeguard Your Pharmacy from Hackers

Some of the most notorious hacks in the past few years have been, and most likely will continue to be, perpetrated by a shadowy group known as Anonymous.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.